China Pharma Holdings (CPHI) Current Leases (2019 - 2026)
China Pharma Holdings' (CPHI) quarterly Current Leases came in at $71386.0 in Q1 2026, up 260.97% YoY from $19776.0 in Q1 2025, and little changed on a QoQ basis from $71628.0 in Q4 2025.
China Pharma Holdings (CPHI) Current Leases (2019 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 8 years of Current Leases data on file, last reported at $71386.0 in Q1 2026.
- Quarterly Current Leases rose 260.97% year-over-year to $71386.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71386.0 (up 260.97% YoY) and the FY2025 annual result came in at $71628.0, up 82.15% from the prior year.
- Current Leases steadied at $71386.0 in Q1 2026, from $71628.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $86672.0 in Q1 2022 to a low of $19776.0 in Q1 2025.
- A 5-year average of $63001.6 and a median of $71507.0 in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases slumped 76.21% — and 2024, when it jumped 279.71%.
- Tracing CPHI's Current Leases over 5 years: stood at $40445.0 in 2022, then jumped by 92.18% to $77727.0 in 2023, then plunged by 49.41% to $39323.0 in 2024, then jumped by 82.15% to $71628.0 in 2025, then dropped by 0.34% to $71386.0 in 2026.
- The last three Current Leases figures came in at $71386.0 (Q1 2026), $71628.0 (Q4 2025), and $70326.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 73,069.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,386.00 |
| Dec 31, 2025 | 71,628.00 |
| Sep 30, 2025 | 70,326.00 |
| Mar 31, 2025 | 19,776.00 |
| Dec 31, 2024 | 39,323.00 |
| Sep 30, 2024 | 60,241.00 |
| Jun 30, 2024 | 78,628.00 |
| Mar 31, 2024 | 78,284.00 |
| Dec 31, 2023 | 77,727.00 |
| Sep 30, 2023 | 76,000.00 |
| Jun 30, 2023 | 74,850.00 |
| Mar 31, 2023 | 20,617.00 |
| Dec 31, 2022 | 40,445.00 |
| Sep 30, 2022 | 59,163.00 |
| Jun 30, 2022 | 82,959.00 |
| Mar 31, 2022 | 86,672.00 |
| Dec 31, 2021 | 85,282.00 |
| Sep 30, 2021 | 82,851.00 |
| Jun 30, 2021 | 83,707.00 |
| Mar 31, 2021 | 26,743.00 |